These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6716274)

  • 1. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow dependence of propranolol elimination in perfused rat liver.
    Keiding S; Steiness E
    J Pharmacol Exp Ther; 1984 Aug; 230(2):474-7. PubMed ID: 6747843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
    Ching MS; Morgan DJ; Smallwood RA
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1048-54. PubMed ID: 2778709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol elimination as described by the venous equilibrium model using flow perturbations in the isolated perfused rat liver.
    Smallwood RH; Mihaly GW; Smallwood RA; Morgan DJ
    J Pharm Sci; 1988 Apr; 77(4):330-3. PubMed ID: 3379592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver.
    Pang KS; Sherman IA; Schwab AJ; Geng W; Barker F; Dlugosz JA; Cuerrier G; Goresky CA
    Hepatology; 1994 Sep; 20(3):672-83. PubMed ID: 8076925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC; de Lamirande E; Horning MG; Pang KS
    Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.
    Smallwood RH; Morgan DJ; Mihaly GW; Jones DB; Smallwood RA
    J Pharmacokinet Biopharm; 1988 Aug; 16(4):377-96. PubMed ID: 3193365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
    Siebert GA; Hung DY; Chang P; Roberts MS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of route of input on the hepatic disposition of diazepam.
    Sahin S; Rowland M
    J Pharmacol Exp Ther; 2000 Nov; 295(2):836-43. PubMed ID: 11046126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo study of propranolol and metabolite(s) disposition in rat liver.
    Ong H; du Souich P; Marchand C
    Drug Metab Dispos; 1981; 9(6):529-34. PubMed ID: 6120811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of hypoxia on the disposition of propranolol and sodium taurocholate by the isolated perfused rat liver.
    Jones DB; Mihaly GW; Smallwood RA; Webster LK; Morgan DJ; Madsen NP
    Hepatology; 1984; 4(3):461-6. PubMed ID: 6724514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent hepatic handling of l-propranolol determined by multiple indicator dilution method: influence of tissue binding of l-propranolol on its hepatic elimination.
    Miyauchi S; Sawada Y; Iga T; Hanano M; Sugiyama Y
    Biol Pharm Bull; 1993 Oct; 16(10):1019-24. PubMed ID: 8287031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
    Villeneuve JP; Dagenais M; Huet PM; Lapointe R; Roy A; Marleau D
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1327-32. PubMed ID: 9047043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of dimesna to mesna by the isolated perfused rat liver.
    Goren MP; Hsu LC; Li JT
    Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol elimination by right and left fetal liver: studies in the intact isolated perfused fetal sheep liver.
    Ring JA; Ghabrial H; Ching MS; Shulkes A; Smallwood RA; Morgan DJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):535-41. PubMed ID: 9454794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.